Is Zenith Capital Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Zenith Capital Corp (ZHCLF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Zenith Capital Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Zenith Capital Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Zenith Capital Corp?

Muslim investors may consider investing in Zenith Capital Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Zenith Capital Corp classified as NOT COVERED?

Musaffa determines the Shariah status of Zenith Capital Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Zenith Capital Corp updated?

The Shariah compliance status of Zenith Capital Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Zenith Capital Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Zenith Capital Corp?

You can check the latest Shariah compliance status of Zenith Capital Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Zenith Capital Corp. Stock Analysis ZHCLF

United States Health Care Nano Cap

Zenith Capital Corp. is a biotechnology investment company, which engages in the discovery and development of novel therapeutics. The company is headquartered in Calgary, Alberta. The company went IPO on 2020-03-06. The Company’s wholly owned subsidiary, Zenith Epigenetics Ltd. (Zenith Epigenetics), is a clinical-stage biotechnology company focused on the discovery and development of therapeutics for the treatment of cancer and other disorders with significant unmet medical need. Zenith Epigenetics is developing various combinations of bromodomain and extra-terminal (BET) inhibitors with other targeted agents. Its lead compound, ZEN-3694, is in clinical development for various oncologic indications such as metastatic castration-resistant prostate cancer, NUT carcinoma, ovarian cancer and RAS activated tumors.

Key Statistics of Zenith Capital Corp (ZHCLF)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.05$0.05

Today's Open

$0.05

Volume

2000.00

P/E Ratio (TTM)

52 Week Range

$0.00$0.19

Market Cap

530.00K

Avg. Volume

6566.77

Dividend Yield

Financial Metrics & Statements of Zenith Capital Corp (ZHCLF)

FAQ's for Zenith Capital Corp (ZHCLF)

According to Musaffa’s Shariah screening methodology, Zenith Capital Corp (ZHCLF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.